Live from the NIH registry
Studies recruiting near Corpus Christi right now
Top 25 of 60 recruiting studies, sorted by proximity — each links to its official registry page
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Peripheral Arterial Disease
N/A
Observational 14,000 participants sought
Christus Sphon Hospital Corpus Christi-Shoreline — Corpus Christi, Texas (5.3 mi)
· Sponsor: Baylor Research Institute
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Basal Ganglia Germinoma, Diabetes Insipidus
Phase 2
Interventional 240 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 38 — Corpus Christi, Texas (5.3 mi)
· Sponsor: BioStem Technologies
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
CHRISTUS Spohn Cancer Center — Corpus Christi, Texas (5.3 mi)
· Sponsor: Agendia
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Diabetes Mellitus, Type 1
Phase 3
Interventional 300 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Brusco, Corpus Christi, TX /ID# 256746 — Corpus Christi, Texas (5.3 mi)
· Sponsor: AbbVie
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Radiographic Axial Spondyloarthritis
Phase 2
Interventional 315 participants sought
Arthritis Care of Texas ( Site 0048) — Corpus Christi, Texas (5.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Acute Myeloid Leukemia
Phase 3
Interventional 1,186 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Tophaceous Gout
Phase 3
Interventional 250 participants sought
Arthritis & Osteoporosis Center of Coastal Bend — Corpus Christi, Texas (5.3 mi)
· Sponsor: Crystalys Therapeutics
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: Akero Therapeutics, Inc
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Overweight, Obesity
Phase 3
Interventional 1,035 participants sought
Private Practice - Dr. Osvaldo A. Brusco — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
Diabetic Foot Ulcer, Type 1 Diabetes Mellitus
Phase 2
Interventional 30 participants sought
WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline — Corpus Christi, Texas (5.3 mi)
· Sponsor: Estar Medical dba Medical Technologies, LTD
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Phase 2
Interventional 461 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 2
Interventional 180 participants sought
Pinnacle Clinical Research - Corpus Christi — Corpus Christi, Texas (5.3 mi)
· Sponsor: Rivus Pharmaceuticals, Inc.
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Rhabdomyosarcoma
Phase 3
Interventional 342 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
North American Comfilcon A Clinical Study
Astigmatism, Presbyopia
N/A
Observational 182 participants sought
Drs. McIntyre, Garza, Avila and Jurica, Optometrists — Corpus Christi, Texas (5.3 mi)
· Sponsor: CooperVision International Limited (CVIL)
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Growth Hormone Deficiency (GHD)
Phase 3
Interventional 150 participants sought
Lumos Pharma Investigational Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: Lumos Pharma